TTR-related familial amyloid polyneuropathy, normally referred to as hereditary amyloidogenic TTR (hATTR) amyloidosis, is an autosomal dominant disorder with a clinical onset usually before the age of 50 years and an overall survival time of less than 10 years if untreated [2]. This evidence concerns the gene TTR and familial amyloid neuropathy.